Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

D3 receives spin-out award by University of Strathclyde for diagnostic test innovation

Renishaw : 10 January, 2008  (New Product)
D3 Technologies, a leader in Surface Enhanced Raman Spectroscopy (SERS), and a subsidiary of world-leading metrology and spectroscopy company Renishaw has received a spin-out recognition award at the University of Strathclyde Enterprise Awards.
The award recognised D3 for its work on trace detection used in drug development, forensic science and medical diagnostics.

A successful spin-out from the University of Strathclyde, D3 Technologies attracted the interest of Renishaw, which acquired a 75 percent interest in the newly formed company in July 2007. Part of the investment was then used by D3 to purchase the business and assets of the analytical business unit operated by Mesophotonics, a spin-out company from the University of Southampton. The ABU develops and manufactures substrates used in SERS applications.

The Strathclyde Enterprise Awards aim to give recognition to some of Scotland’s smartest and most inventive businesses which have been supported by the University's enterprise network. At the awards ceremony hosted by stv presenter Debi Edward, nine awards were granted for projects as diverse as drug development, website creation, environmentally-sound kettles and coffee cups with adaptable handles.

Speaking about his company’s award, Professor Ewen Smith, D3’s CEO, said, “We are delighted to receive this award which recognises the work of all our team in developing improved DNA-based diagnostic tests to detect diseases, or the genetic predisposition to diseases. I would also like to thank the University of Strathclyde and Renishaw for their support and belief in the work of D3.”

Dr David McBeth, director of research and innovation at Strathclyde, said: 'The awards have been presented to give credit to the innovative, creative companies the University has advised and supported and to inspire others to follow their example.”

Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo